Bicocca Open Archive

Logo unimib boa
SMITH, ANDREW
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.165
AS - Asia 10.717
EU - Europa 7.977
SA - Sud America 1.313
AF - Africa 199
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 4
Totale 33.406
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.385
VN - Vietnam 3.084
SG - Singapore 3.061
IT - Italia 2.933
CN - Cina 1.999
HK - Hong Kong 1.085
BR - Brasile 975
DE - Germania 921
RU - Federazione Russa 864
CA - Canada 656
SE - Svezia 655
IE - Irlanda 645
GB - Regno Unito 427
FR - Francia 327
IN - India 307
AT - Austria 250
BD - Bangladesh 224
UA - Ucraina 192
KR - Corea 167
FI - Finlandia 128
NL - Olanda 125
AR - Argentina 119
ID - Indonesia 113
TR - Turchia 113
ES - Italia 99
IQ - Iraq 98
DK - Danimarca 95
JP - Giappone 80
ZA - Sudafrica 74
MX - Messico 72
CH - Svizzera 67
PL - Polonia 64
EC - Ecuador 55
PK - Pakistan 49
SA - Arabia Saudita 46
PH - Filippine 45
VE - Venezuela 43
BE - Belgio 35
CO - Colombia 34
AU - Australia 30
PY - Paraguay 29
UZ - Uzbekistan 29
MY - Malesia 28
MA - Marocco 26
LT - Lituania 25
TW - Taiwan 20
TN - Tunisia 19
CL - Cile 18
PE - Perù 17
AE - Emirati Arabi Uniti 16
GR - Grecia 16
IR - Iran 16
JO - Giordania 16
TH - Thailandia 16
CZ - Repubblica Ceca 15
EG - Egitto 14
UY - Uruguay 14
KZ - Kazakistan 13
NP - Nepal 13
RO - Romania 13
DZ - Algeria 12
KE - Kenya 12
CR - Costa Rica 11
IL - Israele 11
OM - Oman 11
ET - Etiopia 10
NO - Norvegia 10
AZ - Azerbaigian 9
HR - Croazia 9
PT - Portogallo 9
BG - Bulgaria 8
LB - Libano 8
AL - Albania 7
BO - Bolivia 7
JM - Giamaica 7
KG - Kirghizistan 7
LV - Lettonia 7
PS - Palestinian Territory 7
DO - Repubblica Dominicana 6
HU - Ungheria 6
PA - Panama 6
RS - Serbia 6
BY - Bielorussia 5
HN - Honduras 5
MN - Mongolia 5
SY - Repubblica araba siriana 5
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
GA - Gabon 3
KW - Kuwait 3
LY - Libia 3
MU - Mauritius 3
NG - Nigeria 3
NI - Nicaragua 3
SC - Seychelles 3
SN - Senegal 3
SV - El Salvador 3
BB - Barbados 2
Totale 33.362
Salva come PNG Salva come JPEG
Città #
Singapore 1.740
Ann Arbor 1.699
Ashburn 1.213
Milan 1.075
San Jose 1.061
Hong Kong 1.046
Ho Chi Minh City 935
Hanoi 723
Dublin 630
Frankfurt am Main 593
Fairfield 585
Chandler 581
Toronto 482
Wilmington 460
New York 400
Woodbridge 365
Houston 347
Santa Clara 319
Los Angeles 311
Dearborn 306
Dallas 276
Seattle 262
Beijing 257
Chicago 212
Vienna 210
Hefei 201
Princeton 191
Cambridge 185
Shanghai 162
The Dalles 160
Rome 156
Jacksonville 151
Seoul 145
Nanjing 135
São Paulo 122
Buffalo 119
Lauterbourg 115
Council Bluffs 111
Dong Ket 111
Da Nang 101
Moscow 93
Boardman 81
Helsinki 78
Ha Long 73
Haiphong 72
Orem 68
Hải Dương 65
Quận Bình Thạnh 63
Jakarta 62
Kent 59
London 58
Biên Hòa 57
Guangzhou 55
Chennai 53
Lawrence 49
Tokyo 49
Columbus 48
Montreal 48
Thái Nguyên 48
Turin 48
Nanchang 46
Nuremberg 46
Warsaw 45
Baghdad 43
Munich 43
Vũng Tàu 43
Atlanta 42
Brooklyn 42
Denver 42
Altamura 41
Can Tho 41
Ninh Bình 40
Shenyang 40
Bắc Ninh 38
Lissone 38
Falls Church 37
San Diego 37
Washington 37
Johannesburg 36
Manchester 36
Sesto San Giovanni 35
Phoenix 34
Poplar 34
Zurich 34
Bắc Giang 32
Fremont 32
Stockholm 32
Basingstoke 31
Changsha 31
Florence 31
Naples 30
Salt Lake City 30
Amsterdam 29
Hebei 29
Ottawa 29
Pune 29
Zhengzhou 29
Andover 28
Tashkent 28
Brussels 27
Totale 20.907
Salva come PNG Salva come JPEG
Nome #
Viewing coffee fine roots under a molecular lens: Mapping the distribution of relevant metabolites by MALDI-MS imaging 598
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 592
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 560
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 541
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 479
Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI 468
MALDI mass spectrometry imaging shows a gradual change in the proteome landscape during mouse ovarian folliculogenesis 464
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 458
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 451
The putative role of MALDI-MSI in the study of Membranous Nephropathy 431
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 422
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 422
The proteomic landscape of renal tumors 408
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 401
MALDI imaging in Fabry nephropathy: a multicenter study 398
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 391
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 388
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 381
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 381
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 379
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 376
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 374
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 372
Proteomics for the diagnosis of thyroid lesions: Preliminary report 364
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 364
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 359
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 357
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 357
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 357
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 356
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 352
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 351
Proteomics for the study of new biomarkers in Fabry disease: State of the art 346
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 335
Tumor size, stage and grade alterations of urinary peptidome in RCC 327
Proteome analysis in thyroid pathology 325
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 317
Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics 314
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 312
The journey towards clinical adoption of MALDI-MS-based imaging proteomics: from current challenges to future expectations 308
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 304
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 295
The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours 293
A molecular imaging approach to individuate tumour infiltrating lymphocytes 289
Intraluminal proteome and peptidome of human urinary extracellular vesicles 288
MALDI-MSI in the study of glomerulonephritis: Possible molecular indicators of CKD progression 283
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 276
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 274
Exploring 6-aza-2-Thiothymine as a MALDI-MSI Matrix for Spatial Lipidomics of Formalin-Fixed Paraffin-Embedded Clinical Samples 272
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 272
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 272
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 272
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 264
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 256
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 255
Machine learning approaches in MALDI-MSI: clinical applications 255
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles 252
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 250
The role of fine needle aspiration of orbital lesions: A case series 246
MALDI-MS imaging in the study of glomerulonephritis 244
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 243
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 243
Single-follicle spatial proteomics of the whole ovary by MALDI mass spectrometry imaging: towards the identification of protein-markers of the follicle's quality 241
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 241
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 237
Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas 236
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 233
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 226
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 225
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 223
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 217
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 216
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 215
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 214
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 211
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 210
The putative role of MALDI-MSI in the study of Membranous Nephropathy 208
The putative role of MALDI-MSI in the study of Membranous Nephropathy 202
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 201
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 200
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 200
Image segmentation with Bayesian mixtures models for multiomics MSI analyses 198
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 190
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 189
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 187
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 186
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 186
Single-slide detection and typing of AL renal amyloidosis: combining mass spectrometry imaging and digital pathology 185
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 185
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 185
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 184
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 182
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 181
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 177
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 175
Machine Learning for Monoclonal Gammopathies of Renal Significance Risk Stratification Using Clinical and Pathology Data 172
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 171
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 167
Does the urinary proteome reflect ccrcc stage and grade progression? 163
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 161
Totale 29.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.323
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.323
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021243 0 0 0 0 0 0 0 0 0 0 0 243
2021/20221.493 119 144 91 162 114 145 39 83 61 113 149 273
2022/20232.579 300 692 242 199 101 394 47 200 172 37 113 82
2023/20242.140 75 85 82 145 198 585 438 52 132 36 82 230
2024/20255.111 226 452 344 214 439 183 310 196 600 785 567 795
2025/202616.168 2.847 1.521 1.056 1.547 1.540 639 1.987 650 1.050 1.246 1.025 1.060
Totale 34.383